Why the study?
Is cardioversion followed by aspirin alone or with amiodarone cost-effective in patients with nonvalvular atrial fibrillation?
Is cardioversion followed by aspirin alone or with amiodarone cost-effective in patients with nonvalvular atrial fibrillation?
Cardioversion followed by aspirin alone or with amiodarone is a cost-effective strategy for managing nonvalvular atrial fibrillation.
Answers are grounded in this paper and cite their sources.
Supports cardioversion plus aspirin (with or without amiodarone) as a value-based option in nonvalvular AF; extends RCT economic evidence for rhythm control.
EconomicsJanuary 1, 1999Cardioversion followed by aspirin alone or with amiodarone was cost-effective for nonvalvular atrial fibrillationGraham Nichol, MD, Martin S. Green, MDGraham Nichol, MDLoeb Health Research Institute (G.N.)Search for more papers by this author, Martin S. Green, MDOttawa Heart Institute, Ottawa, Ontario, Canada (M.S.G.)Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/ACPJC-1999-130-1-024 SectionsAboutFull Text ToolsAdd to favoritesDownload CitationsTrack Citations ShareFacebookTwitterLinkedInRedditEmail Source CitationEckman MH, Falk RH, Pauker SG. Cost-effectiveness of therapies for patients with nonvalvular atrial fibrillation. Arch Intern Med. 1998 Aug 10/24;158:1669-77.References1 Garber AM, Phelps CE. Economic foundations of cost-effectiveness analysis. J Health Economics. 1997;16:1-31. Google Scholar2 Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Intern Med. 1994;154:1449-57. Google Scholar3 The Planning and Steering Committees of the AFFIRM Study for the NHLBI AFFIRM Investigators. Atrial fibrillation follow-up investigation of rhythm management—the AFFIRM study design. Am J Cardiol. 1997;79:1198-202. Google Scholar4 Klein AL, Grimm RA, Black IW, et al. Cardioversion guided by transesophageal echocardiography: the ACUTE pilot study. A randomized controlled trial. Assessment of cardioversion using transesophageal echocardiography. Ann Intern Med. 1997;126:200-9. Google Scholar Author, Article, and Disclosure InformationAffiliations: Loeb Health Research Institute (G.N.)Ottawa Heart Institute, Ottawa, Ontario, Canada (M.S.G.) PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails January 1, 1999Volume 130, Issue 1Page: 24KeywordsAdverse eventsAnticoagulantsAtrial fibrillationFactor analysisHemorrhageInpatientsMarkov modelsMedical risk factorsQuality of lifeStroke ePublished: 9 March 2020 Issue Published: January 1, 1999 Copyright & PermissionsCopyright © 1999 by American College of Physicians. All Rights Reserved.Loading ...
No takes yet. Share an insight, caveat, or question.
Nichol et al. (1999) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: